Amantadine and anticholinergics have been used for several decades as therapy for Parkinson’s disease (PD). In spite of reduced interest in these compounds with the advent of more specific dopaminergic therapies, there remain clinical situations where amantadine and anticholinergics retain clinical usefulness and a role in the contemporary treatment of PD.
|Original language||English (US)|
|Title of host publication||Handbook of Parkinson's Disease, Third Edition|
|Number of pages||18|
|State||Published - Jan 1 2003|
ASJC Scopus subject areas